Captopril suppresses Post-transplantation angiogenic activity in rat allograft coronary vessels
- 1 June 2004
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 23 (6) , 666-673
- https://doi.org/10.1016/j.healun.2003.07.010
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compoundsThe Journal of Heart and Lung Transplantation, 1999
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progressionBreast Cancer Research and Treatment, 1995
- Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitroBiochemical and Biophysical Research Communications, 1992
- Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.Journal of Clinical Investigation, 1992
- The human carotid atherosclerotic plaque stimulates angiogenesis on the chick chorioallantoic membraneAtherosclerosis, 1992
- Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGFScience, 1989
- Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular InjuryScience, 1989
- Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.Journal of Clinical Investigation, 1989
- Angiogenesis is stimulated by a tumor‐derived endothelial cell growth factorJournal of Cellular Biochemistry, 1985